MustGrow Biologics - Ag-Biotech Company Moving Toward Commercialization Of Its Technology

I was introduced to MustGrow Biologics (TSX.V:MGRO - OTCQB:MGROF) late last year at a conference in Vancouver. The Company is a Bio-Tech company whose technology extracts and concentrates natural compounds from the mustard plant for use as a natural, organic bio-pesticides.

 

Corey Giasson, President and CEO of MustGrow Biologics joins us to introduce the Company's strategy to bring the technology to commercialization. We start with an overview of the technology and global pesticide market. The next big strep for the Company will be to bring this technology to commercialization and mass production. On this front we ask Corey about the trials already undertaken with major companies as partners and what

 

At the end of the interview we cover some other Company fundamentals including share structure, cash position and key news to watch for over the next 6-12 months.

 

If you would like any further information on MustGrow or have any follow up questions for Corey please email me at Fleck@kereport.com.

 

Click here to visit the MustGrow website and read over the Corporate Presentation.